SFA-002

· SFA Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SFA-002, covering 2025-03-11 to 2025-03-11. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Otezla to SFA-002 to Placebo in Plaque Psoriasis Patients [Phase 2, Phase 3]